Clinical Trial Update: An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome [Phase 3]

View source ↗

Summary

An extension study of KCT-0809 for dry eye in Sjögren's syndrome (Phase 3) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Sjögren Syndrome

Drugs mentioned

• KCT-0809

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Dry Eye With Sjögren's Syndrome | Phase 3 | Status: TERMINATED